News Industry News New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA® Will Be Presented at the European Society of Cardiology August 20, 2015
News Daily News Self-Reported Financial Conflicts Have No Effect on Cardiovascular Trial Outcomes Caitlin E. Cox February 07, 2013
News Daily News Los Conflictos de Interés Económico informados por los propios Investigadores No Influyen en los Resultados Cardiovasculares de los Ensayos Caitlin E. Cox February 07, 2013
News Daily News Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk L.A. McKeown June 03, 2011